Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian ...

Salarius subsidiary Decoy Therapeutics’ influenza fusion inhibitors, designed using its proprietary IMP3ACT™ platform, show excellent in silico ...